Skip to content

Meditation Art Therapy: AIGC-Assisted Psychotherapy to Improve Anxiety in Retired People

Yixin Yu, Yashi Shuai, Ran Wan

Frontiers in Artificial Intelligence and Applications March 22, 2024 DOI: 10.3233/faia240063 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 40
Population Retired people with anxiety symptoms
Intervention Mindfulness meditation
Measures HAM-A
Topics Anxiety Meditation Psychedelic-assisted therapy
Key findings AIGC-assisted mindfulness meditation was reported to improve anxiety symptoms in retired people more than meditation alone; the AIGC group's HAM-A score fell to 19.65 (SD=4.84) versus 20.55 (SD=1.43) in the meditation-only group, with significant improvement reported on anxious mood, cognitive, depressive mood, and behavior-at-interview items in the AIGC group but not the meditation group.

Abstract

This study aimed to explore the effect of artificial intelligence-generated artwork (AIGC) as an adjunct to mindfulness meditation on the improvement of anxiety symptoms in retired people. We recruited a group of retired people with anxiety symptoms and randomly divided them into two groups: the mindfulness meditation group (N=20) and the mindfulness meditation +AIGC group (N=20). The mindfulness meditation group received traditional mindfulness meditation training, while the mindfulness meditation +AIGC group used AI to generate paintings related to the meditation theme after the meditation. The results showed that AIGC-assisted mindfulness meditation significantly improved anxiety symptoms in retired people. After treatment, the average HAM-A score decreased to 19.65 (SD=4.84) in the AIGC group, while the meditation group also improved, with an average HAM-A score decreased to 20.55 (SD=1.43). Independent sample t test showed that the AIGC group had significant improvement in Anxious mood, Cognitive, Depressive mood, and Behavior at interview (p<0.01**), while the meditation group(Medi group) had no significant improvement (p<0.05*). The results of this study verified that AIGC in auxiliary applications can more significantly improve the mental health of the retired population, and is expected to provide a new treatment approach to improve the mental health of the retired population.

Comparable studies

Other randomized controlled trials on psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Healthy adults, mostly hallucinogen-naïve 2011 Randomized controlled trial n = 18
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Patients with anxiety associated with life-threatening diseases 2014 Randomized controlled trial n = 12
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder Adults aged 25–65 with DSM-IV alcohol dependence and at least 4 heavy drinking days in... 2022 Randomized controlled trial n = 95
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26

Citations in the library

Cites 7

and 2 more in the library

Related reading

Explore topics

Anxiety Meditation Psychedelic-assisted therapy Depression